Press release
Diabetes Therapeutics Market Expected to Reach $186,842 Million, Globally, By Top Leading Companies AstraZeneca plc, Boehringer Ingelheim GmbH, Eli Lilly and Company, GlaxoSmithKline plc, Novartis, Novo Nordisk & Many Others
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4728
The major factor that contributes to the market growth are increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle. Moreover, development of affordable & effective diabetes therapeutics, rise in obese population, consumption of fast food, growth in awareness among people about self-management of diabetes, and support from the government further boost the market growth. However, side effects of diabetic drugs on patients and stringent approval process for these drugs hinder this growth. Moreover, rise in awareness about diabetes care and untapped market opportunities in developing regions are expected to provide numerous opportunities for market growth.
The injectables segment is expected to maintain its dominant position during the analysis period, owing to rise in the prevalence of diabetes, increase in geriatric population, high demand of self-care, and increased awareness about use of insulin (one of the injectables) as an anti-diabetic drug.
Key Findings of the Diabetes Therapeutics Market
-The injectables segment accounted for nearly two-thirds share of the global market in 2016.
-GLP-1 receptor agonists segment expected to grow at a rapid CAGR of 33.1% from 2017 to 2023.
-Insulin segment accounted for more than half of the global market in 2016.
-Asia-Pacific is expected to grow at the highest CAGR of 16.8% from 2017 to 2023.
North America accounted for more than one-third share of the global market in 2016, and is expected to remain dominant throughout the forecast period. This is attributed to the increase in incidence of diabetes, growth in geriatric population, and adoption of sedentary lifestyle of people that leads to diabetes. In addition, presence of highly sophisticated healthcare infrastructure is expected to present new growth opportunities to the players in this market.
The major companies profiled in the report include
-AstraZeneca plc,
-Boehringer Ingelheim GmbH,
-Eli Lilly and Company,
-GlaxoSmithKline plc,
-Johnson & Johnson,
-Merck & Co., Inc.,
-Novartis AG,
-Novo Nordisk,
-Sanofi S.A., and
-Takeda Pharmaceutical Company Limited.
Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/4728
Table Of Content
Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.4.4. Impact analysis
3.5. CLINICAL TRIALS
Access Full Summery @ https://www.alliedmarketresearch.com/diabetes-therapeutics-market
About Us
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetes Therapeutics Market Expected to Reach $186,842 Million, Globally, By Top Leading Companies AstraZeneca plc, Boehringer Ingelheim GmbH, Eli Lilly and Company, GlaxoSmithKline plc, Novartis, Novo Nordisk & Many Others here
News-ID: 1308005 • Views: …
More Releases from Allied Market Research
Sustainable Home Décor Market Growing at 5.5% CAGR to Hit USD 556.3 billion by …
The global Sustainable Home Decor Market Size was valued at $331.0 billion in 2021, and is projected to reach $556.3 billion by 2031, growing at a CAGR of 5.5% from 2022 to 2031. A complete and wide-ranging evaluation of the aspects that drive and restrain market growth is also provided throughout the study. This detailed exploration of the market size and its proper segmentation help the market players define the…
Tomato Puree Market Rapidly Growing Dynamics with Industry Analysis 2032
The global tomato puree industry was valued at $5,189.9 million in 2022, and is projected to reach $7,699.5 million by 2032, registering with a CAGR of 4.1% from 2023 to 2032.
Tomato puree plays a major role in the daily culinary routines of individuals, making significant contributions to the global food and beverage industry. The growing awareness of diverse and authentic flavors, along with a rising interest in international cuisines, has…
Emerging Technologies in Structural Steel Tube Market in Glob: Innovations and F …
According to the report, "the structural steel tube market" was valued at $105.3 billion in 2023, and is estimated to reach $167.5 billion by 2033, growing at a CAGR of 4.8% from 2024 to 2033.
Allied Market Research published a report, titled, "Structural Steel Tube Market By Type (Hot-Rolled Steel and Cold-Rolled Steel), Material (Stainless Steel Tube, Carbon Steel Tube, Alloy Steel Tube, and Others), Sales Type (Direct,…
Costume Jewelry Market Size Worth USD 86.8 billion by 2033 | Growth Rate (CAGR) …
According to a new report published by Allied Market Research, titled, "costume jewelry market" was valued at $45.2 billion in 2023, and is projected to reach $86.8 billion by 2033, growing at a CAGR of 6.8% from 2024 to 2033.
Get Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/2093
Costume jewelry refers to decorative pieces made of inexpensive materials such as base metals, glass, plastic, or synthetic stones, often adorned with…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
